Acacia Research Corporation intends to acquire undervalued businesses primarily in the technology, life sciences, industry and financial services segments in the United States. The company is headquartered in New York, New York.
| Revenue (TTM) | $285.23M |
| Gross Profit (TTM) | $84.48M |
| EBITDA | $51.49M |
| Operating Margin | -26.10% |
| Return on Equity | 4.31% |
| Return on Assets | 0.53% |
| Revenue/Share (TTM) | $2.96 |
| Book Value | $5.63 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | 1.70 |
| EV/Revenue | 0.792 |
| EV/EBITDA | 2.70 |
| Quarterly Earnings Growth (YoY) | -97.50% |
| Quarterly Revenue Growth (YoY) | 2.60% |
| Shares Outstanding | $96.47M |
| Float | $34.08M |
| % Insiders | 1.43% |
| % Institutions | 87.71% |